Regenerx Biopharmaceuticals Inc posts annual revenue of $0.0768 million in 2022
Key fundamental financials- loss of $1.73 million
- Revenue of $0.0768 million
By USInMinutes
Published - Apr 12, 2023, 07:57 AM ET
Last Updated - Jul 18, 2023, 03:58 PM EDT
Regenerx Biopharmaceuticals Inc [RGRX] has reported $1.73 million loss for the fiscal year ending Dec 31, 2022.
Revenue for the year was $0.0768 million with operating income of $1.40 million.
The Bethesda, Maryland (MD)-based company operating in the pharmaceutical preparations sector.
This is a developing story. Click here to receive updates.
------------
NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.
Our Offices
10kInfo, Inc.
13555 SE 36th St
Bellevue, WA 9800610kInfo Data Solutions, Pvt Ltd.
Claywork Create
11 km, Arakere Bannerghatta Rd, Omkar Nagar, Arekere,
Bengaluru, Karnataka 560076
4.2 12182024
Popular News
